KPV 10 mg research product by Vectrum Peptides
Cellular Response Research

KPV — 10 mg

10 mg / vial

KPV is a three-amino-acid fragment of the natural hormone alpha-MSH. Researchers use cell and animal models to study how it moves through surface cells and affects signals linked with inflammation, including in protective linings.

€40,00
Research only Secure checkout Document available Bac Water Needed
For in-vitro laboratory research only. Not for human or veterinary use.This information is provided for scientific and educational product context only. It does not describe or recommend human use, veterinary use, diagnosis, treatment, prevention, dosage, administration, or clinical application.

At a glance

What It Does in the Body

Inflammation Signals

KPV is studied for how it may quiet chemical messages that drive inflammation.

Digestive Lining

Researchers study how KPV enters cells lining the intestines and affects their response to irritation.

Immune Signals

It may affect messages released by immune cells during inflammation.

Surface Repair

Animal research has examined how KPV may affect recovery of protective surface cells, including the eye's outer layer.

NECESSARY RESEARCH EQUIPMENT

Bacteriostatic Water

Available separately for laboratory use.

Document available
Product document

Analytical documentation

Open the document and check that its product and batch details match your item.

Product
KPV — 10 mg
Document type
Analytical document

This document applies only to the product and batch printed on it.

Full research details

Full research details for KPV

Read the supporting laboratory, animal and human research. This section does not provide instructions for human or veterinary use, diagnosis, treatment, prevention, dosage or administration.

What this compound is

KPV is a small peptide made from lysine, proline and valine. It matches the end section of alpha-melanocyte-stimulating hormone, often shortened to alpha-MSH. Researchers use KPV to study how this small fragment behaves without the full hormone. Current sources focus on cell transport, inflammatory signals and protective surface cells.

MaterialThree-amino-acid peptide fragment
Main research areaEpithelial and inflammatory signalling
Evidence availableCell and animal model research
Catalogue categoryCellular Response Research

How It Works

Normal target and function. KPV is studied in relation to PepT1, a transporter that normally moves small peptides across some epithelial cells. Researchers also measure NF-kB and cytokines, which are normal signalling systems cells use to coordinate inflammatory responses. A single direct KPV receptor has not been confirmed.

One research question is how KPV crosses epithelial cells, the cells that form surfaces and barriers. Intestinal studies have examined a transporter called PepT1, which moves small peptides into cells. Researchers then measure signals such as NF-kB and cytokines, which help coordinate inflammation. Other work uses eye-surface injury models. Researchers also check whether the fragment remains intact during each experiment.

Peptide transport

Cell studies examine whether PepT1 moves KPV across intestinal surface cells.

Inflammatory messages

Researchers measure NF-kB and cytokines, signals involved in cell responses to stress.

Surface-cell biology

Work includes epithelial cells that form protective layers in the intestine and cornea.

Fragment research

KPV is studied as a small part of alpha-MSH, not as the complete hormone.

Laboratory and Animal Research

Intestinal cell work has reported PepT1-dependent transport and changes in inflammatory signals. Animal eye-surface and inflammation models have reported changes in epithelial endpoints after controlled injury. These are preclinical observations and do not demonstrate an effect in people.

Measurements used in these studies

  • PepT1-dependent movement of KPV into cells
  • Inflammatory signals measured after a controlled challenge
  • Movement and recovery markers in epithelial cells
  • Differences between KPV and the full alpha-MSH molecule

Research Evidence

Human evidence

The linked evidence comes from intestinal cells and animal surface-tissue models. It does not show whether KPV produces the same signals or any noticeable effect in people.

Adverse effects

Reliable human safety information for KPV is not available, so a product-specific adverse-effect list cannot be supported.

Evidence typeWhat was studiedHow much evidenceWhat this means
Laboratory researchIntestinal cell modelsPreclinicalStudies examined peptide transport and changes in inflammatory signals.
Animal researchCorneal and inflammation modelsPreclinicalAnimal work measured surface-cell endpoints after controlled injury.
Human researchControlled clinical studiesNot establishedThe sources linked on this page do not contain meaningful controlled human research for KPV.